Cargando…
Soluble CD40 ligand inhibits the growth of non-Hodgkin's lymphoma cells through the JNK signaling pathway
The incidence of non-Hodgkin's lymphoma (NHL) has been increasing annually and has become a serious threat to human health. However, the pathogenesis of NHL remains unclear. The present study aimed to investigate the effect of soluble CD40 ligand (sCD40L) on NHL cells and its underlying mechani...
Autores principales: | Feng, Zhongxin, Wang, Jishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709545/ https://www.ncbi.nlm.nih.gov/pubmed/33281967 http://dx.doi.org/10.3892/ol.2020.12318 |
Ejemplares similares
-
The Soluble Factor from Oral Cancer Cell Lines Inhibits Interferon-γ Production by OK-432 via the CD40/CD40 Ligand Pathway
por: Ohe, Go, et al.
Publicado: (2021) -
Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation
Publicado: (1993) -
Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2
por: Aloui, Chaker, et al.
Publicado: (2016) -
Soluble CD40 ligand is not solely related to the presence and severity of sepsis
por: Chew, Michelle S, et al.
Publicado: (2011) -
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway
por: Feng, Zhongxin, et al.
Publicado: (2019)